Meridian Bioscience (VIVO) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Canaccord Genuity Cuts Price Target on Meridian Bioscience (VIVO) Following In-Line Quarter Results
July 27, 2015 9:18 AM EDTCanaccord Genuity reiterated a Hold rating on Meridian Biosciences (NASDAQ: VIVO), and cut the price target to $19.00 (from $20.00), following quarterly results. Revenues of $48.3M narrowly missed the Street's $48.6M. EPS of $0.22 was in line with the Street.
Analyst Mark Massaro... More
Meridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.1% Yield
July 23, 2015 8:26 AM EDTMeridian Bioscience (Nasdaq: VIVO) declared a quarterly dividend of $0.20 per share, or $0.8 annualized.
The dividend will be payable on August 13, 2015, to stockholders of record on August 3, 2015, with an ex-dividend date of July 30, 2015.
The annual yield on the dividend is 4.1 percent.
For... More
